Search the Newsreel

Focus Partners Advisor Solutions LLC Takes $4.38 Million Position in Casey's General Stores, Inc. $CASY

Focus Partners Advisor Solutions LLC has acquired a new stake of 5,511 shares, valued at approximately $4.38 million, in Casey's General Stores, Inc. during the second quarter. Several other institutional investors also adjusted their positions in the company, which reported strong quarterly earnings, surpassing …

Focus Partners Advisor Solutions LLC Acquires New Position in Take-Two Interactive Software, Inc. $TTWO

Focus Partners Advisor Solutions LLC has acquired a new stake of 6,478 shares, valued at approximately $1.62 million, in Take-Two Interactive Software (NASDAQ:TTWO) during the second quarter. This move is part of broader institutional investment, as such investors collectively own 95.46% of the company. …

Focus Partners Advisor Solutions LLC Makes New Investment in General Mills, Inc. $GIS

Focus Partners Advisor Solutions LLC has made a new investment in General Mills, Inc. (NYSE:GIS), purchasing 71,557 shares valued at approximately $2.49 million during the second quarter. This move is part of broader institutional interest, with several other major firms like State Street Corp …

Focus Partners Advisor Solutions LLC Makes New $6.70 Million Investment in General Dynamics Corporation $GD

Focus Partners Advisor Solutions LLC has invested $6.70 million in General Dynamics Corporation by acquiring 18,907 shares. This comes amidst other institutional investors modifying their holdings and various analysts issuing reports with target price adjustments and ratings for General Dynamics, which recently reported strong …

Andar Capital Management HK Ltd Buys Shares of 783,900 Atomera Incorporated $ATOM

Andar Capital Management HK Ltd recently acquired 783,900 shares of Atomera Incorporated (NASDAQ:ATOM) for approximately $90 million, making Atomera its eighth largest holding and representing 2.02% of Atomera’s outstanding stock. Other institutional investors also increased their stakes, bringing total institutional ownership to 30.79%. Despite …

47,412 Shares in General Motors Company $GM Acquired by Bellars Harris Wealth Management LLC

Bellars Harris Wealth Management LLC recently acquired 47,412 shares of General Motors Company (NYSE:GM) valued at approximately $3.655 million, according to its latest SEC filing. Other institutional investors have also adjusted their holdings in GM, with 92.67% of the company's stock owned by institutional …

Mineralys Therapeutics, Inc. $MLYS Shares Bought by Bank of America Corp DE

Apollon Wealth Management LLC Purchases 97,289 Shares of NextEra Energy, Inc. $NEE

Apollon Wealth Management LLC significantly increased its stake in NextEra Energy (NEE) by 44.5% during the second quarter, adding 97,289 shares to own a total of 315,851 shares valued at $27.7 million. This move is part of broader institutional interest, with 78.72% of the …

ABN Amro Investment Solutions Increases Stock Position in NextEra Energy, Inc. $NEE

ABN Amro Investment Solutions significantly increased its stake in NextEra Energy, Inc. (NYSE:NEE) by 58.0% in the second quarter, now owning 159,302 shares worth $13,982,000. Other institutional investors also adjusted their positions in the utilities provider. The article details NextEra Energy's stock performance, recent …

Andar Capital Management HK Ltd Purchases Shares of 18,289,152 Teradyne, Inc. $TER

Andar Capital Management HK Ltd acquired 18.29 million shares of Teradyne, Inc. (NASDAQ:TER) valued at approximately $37.8 million, making it their 12th largest holding. The acquisition accounts for about 11.7% of Teradyne. Despite some insider selling, analysts maintain a "Moderate Buy" rating for Teradyne …

Legal & General shares have a dividend yield of 7.1%. What’s the catch?

Natera (NTRA) Lands New Trial Collaboration But Is The Valuation Already Priced In

Find winning stocks in any market cycle. Join 7 million investors using Simply Wall St's investing ideas for FREE. Natera (NTRA) has drawn fresh attention after announcing a new collaboration that puts its Latitude molecular residual disease test into a Phase 1 clinical trial …

Wall Street Zen Upgrades Avalo Therapeutics (NASDAQ:AVTX) to Hold

Wall Street Zen has upgraded Avalo Therapeutics (NASDAQ:AVTX) from a "sell" to a "hold" rating, though the consensus among other analysts remains a "Moderate Buy" with an average price target of $45.10. The company reported a quarterly loss of $0.83 per share, missing estimates. …

Atara Biotherapeutics (NASDAQ:ATRA) Rating Increased to Hold at Wall Street Zen

Wall Street Zen has upgraded Atara Biotherapeutics (NASDAQ:ATRA) from "Sell" to "Hold," reflecting an average "Hold" consensus among analysts with an average price target of $9.50. Despite the upgrade, ATRA shares opened down 4.9% at $8.09, with the company reporting a quarterly loss of …

Quick Update On Take-Two Interactive Software Stock $TTWO - GTA 6 Might Be Delayed, But Who Cares?!🤪 Marshals (TTgj7Iy2Au)

Dorchester Minerals (DMLP) Could Be 74% Below Fair Value As Earnings Improve

Dollar General (DG), What Is Drawing Fresh Attention Now?

Make better investment decisions with Simply Wall St's easy, visual tools that give you a competitive edge. Dollar General (DG) is back on investors' radar after a recent share price move, with the stock closing at US$123.28. That change, alongside mixed short term returns, …

Should I buy Scribe Therapeutics Inc. (SCTX)

Equity in earnings of Midera Food Processing, Inc. – NASDAQ:MFP

What Interactive Brokers Group (IBKR)'s Push Into Romanian Equities and Brazilian Futures Access Means For Shareholders

Interactive Brokers Group has recently expanded its platform by adding access to the Bucharest Stock Exchange and enabling eligible non-resident clients to trade Brazilian futures on B3, broadening exposure to Romanian equities and Brazilian derivatives alongside more than 170 global markets. This push into …

Why AbCellera (ABCL) Is Up 64.2% After Menopause Trial Win, Equity Raise And Vertex Deal

AbCellera Biologics (ABCL) saw its stock rise by 64.2% following positive Phase 2 results for its menopause drug ABCL635, a US$200 million equity raise, and a new collaboration with Vertex Pharmaceuticals. These developments strengthen its clinical pipeline and funding base, with the Vertex deal …

Midera Food Processing, Inc. Statistics – NASDAQ:MFP

Midera Food Processing, Inc. Income Statement – NASDAQ:MFP

GL4 Forecast — Price Target — Prediction for 2027

This article provides an outlook on Accelerant Holdings Class A (GL4) stock, including analyst price targets, historical performance, and financial data. Analysts have provided 1-year price forecasts, with a maximum estimate of 26.02 EUR and a minimum of 14.75 EUR. The company's past earnings …

Price-Driven Insight from (ZVRA) for Rule-Based Strategy

This article provides a price-driven analysis for Zevra Therapeutics Inc. (NASDAQ: ZVRA), highlighting weak near-term sentiment but strong mid and long-term outlooks. It details institutional trading strategies including position, momentum breakout, and risk hedging, along with multi-timeframe signal analysis, and an exceptional risk-reward short …

Arcutis (ARQT) Q2 2026 Earnings Call Transcript

Top Generate Biomedicines (GENB) Competitors 2026

Nektar Therapeutics (NKTR) Stock Slides As Cash Burn Clouds Pipeline Progress

Nektar Therapeutics' stock fell 4% following its Q2 2026 earnings report, despite progress in its autoimmune pipeline, notably rezpegaldesleukin. The market reacted negatively to the company's substantial cash burn, with a quarterly net loss exceeding US$40 million and trailing 12-month losses widening. While the …

Is Veracyte (VCYT) Undervalued As Raised 2026 Outlook And Q2 Earnings Lift Interest?

Veracyte (VCYT) is attracting investor attention after raising its 2026 revenue outlook and reporting a shift from net loss to net income in Q2, driven by new cancer diagnostics. Despite a recent share price pullback, its longer-term performance remains strong, with a 90-day return …

Understanding Momentum Shifts in (VLTO)

This article analyzes Veralto Corp (NASDAQ: VLTO) using AI models to identify momentum shifts and provide trading strategies. Key findings indicate mixed sentiment across different time horizons and no clear resistance levels above the current price, suggesting potential upside. Three distinct institutional trading strategies—Position …

Interactive Brokers Group (IBKR) Expands Into Romania And Brazil, Is It Still Undervalued?

Track your investments for FREE with Simply Wall St, the portfolio command center trusted by over 7 million individual investors worldwide. Interactive Brokers Group (IBKR) has opened access to the Bucharest Stock Exchange and expanded Brazilian futures trading on B3, giving clients more ways …

Usiminas (BOVESPA:USIM5) Stock Fair Value Moves Lower As Analysts Split On Steel Outlook

Find your next quality investment with Simply Wall St's easy and powerful screener, trusted by over 7 million individual investors worldwide. The updated fair value price target for Usinas Siderúrgicas de Minas Gerais has shifted from R$9.59 to about R$8.87, which sits between the …

AbCellera (ABCL) Soars 64% as Drug Candidate Holds Huge Market Opportunity

AbCellera (ABCL) saw its stock price jump by 64% last week, becoming the top-performing mid-cap stock in the US market, following strong phase 2 clinical trial results for its drug candidate ABCL635 for hot flashes in menopausal women. The drug successfully reduced hot flash …

The Army gave General Dynamics $533M to build an artillery plant that produced nothing

The U.S. Army spent $533 million on a General Dynamics artillery plant in Mesquite, Texas, intended to produce shells for Ukraine, but the facility never yielded a single usable shell. Despite promises of innovative Turkish-made robots, the plant was plagued by repeated failures, including …

ELTX Stock Heads For Worst Day Ever — Elicio Therapeutics' Pancreatic Cancer Data Disappoints

Is General Mills (GIS) Reasonable for Value Investors Today?

Make better investment decisions with Simply Wall St's easy, visual tools that give you a competitive edge. General Mills stock has had a weak run over the past few years, while current valuation checks suggest the shares are neither a clear bargain nor obviously …